Myeloma Trial, Recruiting (NCT01351545)

Myeloma Trial, Recruiting NCT01351545 Sponsor: Center for International Blood and Marrow Transplant Research Condition: Myeloma

Printed from Voxsanity (voxsanity.com.au) — NCT01351545 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Myeloma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have a condition affecting the blood system (such as a disease you were born with, one that developed over time, or one caused by strong treatments that destroyed your bone marrow)
You (or your guardian) have signed a consent form agreeing to take part before the study begins
People of any age, including children and adults, may be eligible

Who may not be able to join:

You are only receiving cord blood units that have already been fully approved by regulators (not investigational ones)
You are having a cord blood transplant at a transplant center located outside the country where this trial is based
You are already enrolled in another research study specifically to access the unapproved cord blood unit(s) being used in your treatment
The cord blood unit(s) chosen for you will go through more than very minor processing or alteration before being used (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT01351545

Sponsor: Center for International Blood and Marrow Transplant Research

Phase: Not Applicable

Status: Recruiting

Condition: Myeloma

More information: https://clinicaltrials.gov/study/NCT01351545

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have a condition affecting the blood system (such as a disease you were born with, one that developed over time, or one caused by strong treatments that destroyed your bone marrow)
You (or your guardian) have signed a consent form agreeing to take part before the study begins
People of any age, including children and adults, may be eligible

Who may not be able to join:

You are only receiving cord blood units that have already been fully approved by regulators (not investigational ones)
You are having a cord blood transplant at a transplant center located outside the country where this trial is based
You are already enrolled in another research study specifically to access the unapproved cord blood unit(s) being used in your treatment
The cord blood unit(s) chosen for you will go through more than very minor processing or alteration before being used (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Center for International Blood and Marrow Transplant Research

Registry

ClinicalTrials.gov

Start date

1 October 2011

Est. completion

1 October 2041

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Neutrophil recovery of ≥500/mm3 after cord blood transplantation; Neutrophil recovery of ≥500/mm3 after cord blood transplantation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov